Andrew Grandinetti, PhD
- PhD (Biomedical Sciences-Epidemiology) University of Hawai‘i at Mānoa
- MS (Public Health) University of Hawai‘i at Mānoa
- BA (Anthropology) University of Hawai‘i at Mānoa
Current Research Grants
2006-2008 Nutritional Risk Factors for Type 2 Diabetes in the Multiethnic Cohort (G. Maskarinec)
2007-2008 Volcanic Emissions and Airway function, Inflammation, heart Rhythm (AIR) CDC EH05-056 (sub-study; Feasibility of measuring airway function, inflammation, and autonomic function/ heart rate variability)
Dr. Grandinetti's area of interest is on disparities in the prevalence of diabetes, diabetes complications, and cardiovascular risk factors in Hawai‘i's multi-ethnic population. His current research is focused on the neurological complications of diabetes and the effects of insulin resistance on neurological function, in collaboration with Dr. Phillip Low of the Mayo Clinic in Rochester, MN. This ongoing clinical study is recruiting residents of the rural community of Kohala, on the Island of Hawai‘i. Dr. Grandinetti also collaborates with the Pacific Health Research Institute's Parkinson Disease research group, which has been investigating the risk factors for this debilitating neurodegenerative disease among survivors of the Honolulu Heart Program cohort.
Grandinetti A, Chow DC, Sletten DM, Oyama JK, Theriault AG, Schatz IJ, et al. Impaired glucose tolerance is associated with postganglionic sudomotor impairment. Clin Auton Res 2007;17(4):231-3.
Grandinetti A, Kaholokula JK, Theriault AG, Mor JM, Chang HK, Waslien C. Prevalence of diabetes and glucose intolerance in an ethnically diverse rural community of Hawaii. Ethn Dis 2007;17(2):250-5.
Kurahara DK, Grandinetti A, Fujii :, Tokuda A, Galario J, Han M, Terrell M, Yamamoto K, Yamaga K, Person DA. Visiting consultant clinics to study prevalence rates of juvenile rheumatoid arthritis and childhood systemic lupus erythematosus across dispersed geographic areas. J Rheumatol 2007;34(2):425-9.